THE problem of systemic arterial embolism in rheumatic heart disease does not end after the patient has survived the acute episode. As protection from re-embolism, which threatens in some 45 per cent ...

A new device designed to close the left atrial appendage (LAA) and prevent strokes in patients with atrial fibrillation (A-fib) demonstrates a high rate of successful closure with minimal access ...

Please provide your email address to receive an email when new articles are posted on . Outcomes for ablation of persistent AF by pulmonary vein antral isolation (PVAI) alone have been historically ...

Please provide your email address to receive an email when new articles are posted on . After successful percutaneous left atrial appendage ligation with the Lariat device, incomplete closure of the ...

Boca Raton Regional Hospital's Richard G. Cartledge, MD, FACS, has begun performing ultra-minimally invasive left atrial appendage ligation for atrial fibrillation patients who are on anticoagulants ...

Surgically ligating the left atrial appendage (LAA) during implantation of the HeartMate 3 left ventricular assist device (LVAD; Abbott) does not affect survival or hemocompatibility-related adverse ...

The left atrial appendage (LAA), a site of predilection for thrombus formation, is the primary source of thromboemboli in patients with nonvalvular atrial fibrillation (NVAF) who have a stroke ...

Atrial fibrillation (AF) is a major risk factor for disabling ischemic strokes. Anticoagulation is highly effective for stroke prevention in patients with AF, but a substantial number of patients are ...